The inspection was conducted from March 2-6.
SMS Pharmaceuticals share price rose 13 percent intraday on March 9 after the US drug regulator completed an inspection with zero observation.
The United States Food and Drug Administration (USFDA) conducted a regulatory inspection of the testing facility Central Laboratory Analytical Services from March 2 to 6, the company said in a release.
The audit resulted in zero observation, it said.
At 11:16 hours, SMS Pharmaceuticals was quoting at Rs 36.90, down Rs 0.05, or 0.14 percent, on the BSE.
Time to show-off your poker skills and win Rs.25 lakhs with no investment. Register Now!
First Published on Mar 9, 2020 11:30 am
